Integrated, research-driven pharmaceutical manufacturer of affordable APIs and finished-dosage medicines across oncology, cardiology, CNS, diabetes, nephrology, urology, gastroenterology and orthopaedics. Features integrated R&D and global manufacturing with a broad portfolio (500+ APIs, 400+ finished dosages) and rapid product introduction.